Association of chemokines IP-10/CXCL10 and I-TAC/CXCL11 with insulin resistance and enhance leukocyte endothelial arrest in obesity.
Autores de INCLIVA
Participantes ajenos a INCLIVA
- Moreno, Beatriz
Grupos y Plataformas de I+D+i
Abstract
BACKGROUND AND AIMS: Obesity is a key contributing factor to incidental type 2 diabetes and cardiovascular disease. CXCR3 receptor and its ligands CXCL 10 and 11 are associated with atherosclerosis and cardiovascular disease. The aim of our study was to analyse the role of the CXCR3 ligands on insulin resistance (IR) and endothelial dysfunction in human obesity. METHODS AND RESULTS: We have studied 45 obese patients (mean age 44 ± 6 years, body mass index 45 ± 9 kg/m(2)) who were selected for Roux-Y-gastric bypass surgery and 21 non obese control subjects with similar age and gender distribution. We measured by ELISA the circulating levels of the CXCR3 ligands interferon-? inducible protein 10 (IP-10/CXCL10) and interferon-?-inducible T-cell alpha chemoattractant (I-TAC/CXCL11). Using an ex vivo procedure with the flow chamber assay, we have investigated the effect of such chemokines on endothelial leukocytes arrest under dynamic conditions. Peripheral blood levels of CXCL10 and CXCL11 were significantly higher in obese subjects than in controls (p < 0.001) and significantly correlated with BMI, waist circunference and HOMA-IR. Obese patients with HOMA-IR index above 75th percentile showed highest increase of circulating CXCL10 and CXCL11 values. Under dynamic flow conditions, the enhanced adhesion of patient leukocytes to TNFa-induced human arterial endothelial cells was partly dependent on CXCR3. CONCLUSIONS: The study demonstrates that CXCL10 and CXCL11 are associated with IR and enhance leukocyte endothelial arrest in obese subjects. Blockade of CXCR3 signaling might be a new therapeutic approach for the prevention of obesity-associated cardiovascular co-morbidities.
Copyright © 2021 Elsevier Inc. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 0026-2862, 1095-9319
- Tipo:
- Article
- Páginas:
- 104254-104254
- PubMed:
- 34534571
MICROVASCULAR RESEARCH Elsevier Inc.
Citas Recibidas en Web of Science: 21
Documentos
- No hay documentos
Filiaciones
Keywords
- CXCL10; CXCL11; CXCR3; Chemokines; Endothelial dysfunction; Insulin resistance; Leukocyte adhesion; Obesity
Financiación
Proyectos y Estudios Clínicos
Estudio de nuevos mecanismos inflamatorios y angiogénicos asociados a la obesidad grave morbida: papel del eje CXCR3 y los receptores RORs.
Investigador Principal: LAURA PIQUERAS RUIZ
PI15/00082 . INSTITUTO SALUD CARLOS III . 2016
RETOS 2017. MODULACION FARMACOLOGICA DEL SISTEMA INMUNE COMO DIANA CLAVE EN LA PREVENCION DE LA ENFERMEDAD CARDIOVASCULAR ASOCIADA A DESORDENES METABOLICOS. SINTESIS DE FARMACOS NOVEDOSOS
Investigador Principal: MARIA JESUS SANZ FERRANDO
SAF2017-89714-R . MINISTERIO ECONOMIA Y COMPETITIVIDAD . 2018
Identificación de nuevos mecanismos implicados en la angiogénesis e inflamación en pacientes obesos. Modulación por ligandos de receptores nucleares constitutivos de androstano.
Investigador Principal: JOSE TOMAS REAL COLLADO
PI18/00209 . INSTITUTO SALUD CARLOS III . 2019
Efecto de la cirugía bariátrica en la inflamación vascular en pacientes con obesidad morbida y diabéticos.
Investigador Principal: LAURA PIQUERAS RUIZ
AICO/2019/250 . CONSELLERIA EDUCACION/INNOVACION,UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL/EMPLEO . 2019
CONTRATOS PREDOCTORALES DE FORMACIÓN EN INVESTIGACIÓN EN SALUD.
Investigador Principal: LUISA MARIA HUESO SOLER
FI19/00033 . INSTITUTO SALUD CARLOS III
Cita
Moreno B,Hueso L,0000-0003-0228-4345,Benito E,Sergio H,Peiro M,Civera M,Sanz M,Piqueras L,Real JT. Association of chemokines IP-10/CXCL10 and I-TAC/CXCL11 with insulin resistance and enhance leukocyte endothelial arrest in obesity. Microvasc Res. 2022. 139. p. 104254-104254. IF:3,100. (2).
Association of chemokines IP-10/CXCL10 and I-TAC/CXCL11 with insulin resistance and enhance leukocyte endothelial arrest in obesity. Moreno B, Hueso L, 0000-0003-0228-4345, Benito E, Sergio H, Peiro M, Civera M et al. MICROVASCULAR RESEARCH. 2022 enero 01. 139104254-104254. DOI:10.1016/j.mvr.2021.104254. PMID:34534571.